Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/24 16:13 | 5/14/24 | LENZ | Health | BioPrd | Biological Products, (No Diag | Chevallard Daniel R. | CA | O | CFO | 1 | P | 50 | 15.68 | 0 | 3 | 3 | D | |||||||||||||||
5/14/24 17:29 | 5/13/24 | LENZ | Health | BioPrd | Biological Products, (No Diag | McCollum James W | CA | D | 1 | P | 501 | 15.99 | 0 | 31 | 5 | 621 | I | |||||||||||||||
3/25/24 20:48 | 3/21/24 | LENZ | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | 1 | P.d | 15,000 | 15.03 | 0 | 998 | 33 | 4,014 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |